Newsletter March 2017 No.178
Top News
Held the Regular Chairman's Press Conference.
On January 17, 2017, the Pharmaceutical Manufacturers Association of Japan (PMAJ) held its "Regular Chairman's Press Conference" at the Nomura Conference Plaza Nihonbashi (Chuo-ku, Tokyo). At the press conference, Yoshihiko Hatanaka, Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), gave a presentation on "I. Creation and Evaluation of Drug Innovation," "II. Toward Reform of the NHI Drug Price System," and "III. Promotion of Drug Discovery Innovation," explaining the basic concept of the Pharmaceutical Manufacturers Association of Japan (PMAJ) and its specific initiatives. Seventy-two members of the press attended this press conference and engaged in a lively Q&A session.
Topics
- Lecture commemorating the completion of the new exhibition room "Drugs Room - Kusurium" at the Science Museum
- Public recording of the Pharmaceutical Manufacturers Association of Japan's special program "Nuchigusui na Monogatari -Listen and Feel At Ease About Medicines-" broadcast by Okinawa Television Broadcasting Corporation
- Held the 22nd Environmental Safety Seminar
- U.S. Pharmaceutical Regulatory Affairs Seminar" - U.S. FDA's Proposed Revision of GLP to Strengthen the Quality System and Four Priority Review Programs for the Early Approval of Breakthrough New Drugs
- The 4th Taiwan-Japan Pharmaceutical Exchange Conference" was held.
- CMC Strategy Forum Japan 2016" was held.
Citizens, Patients and Musubu
Policy Research Institute page
Internet of Things (IoT) in medicine and healthcare
From JPMA
Contributing to Society through the Creation of Innovative Medicines